Free Trial
NASDAQ:ENVB

Enveric Biosciences (ENVB) Stock Price, News & Analysis

$0.47
0.00 (0.00%)
(As of 07/22/2024 ET)
Today's Range
$0.45
$0.53
50-Day Range
$0.45
$0.90
52-Week Range
$0.41
$3.90
Volume
534,970 shs
Average Volume
321,712 shs
Market Capitalization
$3.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.00

Enveric Biosciences MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
2,045.9% Upside
$10.00 Price Target
Short Interest
Healthy
1.95% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.98) to ($1.02) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.90 out of 5 stars

ENVB stock logo

About Enveric Biosciences Stock (NASDAQ:ENVB)

Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.

ENVB Stock Price History

ENVB Stock News Headlines

Next opportunity for crypto millions
The Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…
Next opportunity for crypto millions
The Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has led to a massive bull run in the year after it happens. That means we're in the "golden window" right now…
Enveric Biosciences Inc (ENVB)
See More Headlines
Receive ENVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/14/2024
Today
7/22/2024
Next Earnings (Estimated)
8/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ENVB
Employees
7
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$10.00
High Stock Price Target
$10.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+2,045.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-17,290,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.71 per share

Miscellaneous

Free Float
7,859,000
Market Cap
$3.70 million
Optionable
Not Optionable
Beta
0.74
Beginner's Guide to Pot Stock Investing Cover

Click the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise.

Get This Free Report

Key Executives

  • Dr. Joseph Edward Tucker Ph.D. (Age 55)
    CEO & Director
    Comp: $450.79k
  • Mr. Kevin M. Coveney CPA (Age 60)
    Chief Financial Officer
    Comp: $385.62k
  • Dr. Peter J. Facchini Ph.D. (Age 60)
    Chief Innovation Officer
    Comp: $233.27k

ENVB Stock Analysis - Frequently Asked Questions

How have ENVB shares performed this year?

Enveric Biosciences' stock was trading at $1.30 at the beginning of the year. Since then, ENVB shares have decreased by 64.2% and is now trading at $0.4660.
View the best growth stocks for 2024 here
.

How were Enveric Biosciences' earnings last quarter?

Enveric Biosciences, Inc. (NASDAQ:ENVB) released its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.61) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.61).

When did Enveric Biosciences' stock split?

Enveric Biosciences's stock reverse split on the morning of Friday, July 15th 2022. The 1-50 reverse split was announced on Friday, July 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, July 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

How do I buy shares of Enveric Biosciences?

Shares of ENVB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ENVB) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners